Non-financial boards have been closed but will continue to be accessible in read-only form. If you're disappointed, we understand. Thank you for being an active participant in this community. We have more community features in development that we look forward to sharing soon.
For people with type 1 diabetes (T1D), managing blood-sugar levels is a constant challenge. No matter how hard they work, many people with T1D spend a part of every day with blood-sugar levels outside the healthy range. Not only does this feel lousy, it’s really dangerous and potentially life-threatening. That’s why JDRF is committed to advancing technology like artificial pancreas systems that can automate blood-sugar management, making life with T1D easier and safer overall.While these systems can do much of the heavy lifting involved in managing T1D, they come with burdens of their own. Current systems include an insulin pump and delivery mechanism and a glucose sensor, both of which must be attached to the body, poked through the skin and replaced every few days. These drawbacks can deter people from using these systems, so JDRF is working to make them more user-friendly.http://www.jdrf.org/blog/2017/12/20/improving-devices-improv...The stress of managing diabetes can take its toll. Knowing how to ease your mind and body in anxious moments can contribute to a sense of security. “The idea is to make healthy reactions habitual so you turn to them instead of going into distress too deeply,” says Camilla Levister, ANP-C, CDE, a diabetes educator with Mount Sinai Diabetes Center in New York City.Read on for nine strategies to help you feel safe and centered.http://www.diabetesforecast.org/2017/jan-feb/9-ways-to-ease-...We have serious concerns about the article, “Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply Chain,” published in the Journal of Diabetes Science and Technology on December 21, 2017. The article describes measuring insulin concentration in vials of human insulin (regular and NPH) from different pharmacies at different times of the year, from two different manufacturers. The authors report a mean potency of approximately 40 U/ml instead of the FDA-mandated >95 U/ml, with the regular human insulin alone averaging less than 25 U/ml potency and the NPH at approximately 55 U/ml.http://diabetesstopshere.org/2018/01/22/insulin-concentratio...FuskieWho is now off Glipizide ER and ramping up on taking Trulicity weekly to try and manage his blood glucose...-----Ticker Guide for The Walt Disney Company (DIS), Orbital ATK (OA), Global Payments (GPN), Time Warner (TWX), Titan International (TWI)Disclaimer: This post is non-professional and should not be construed as direct, individual or accurate adviceDisclosure: May own shares of some, many or all of the companies mentioned in this post (tinyurl.com/FuskieDisclosure)Fool Code of Conduct: http://tinyurl.com/FoolCode
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |